Vaccines Need A Modern Cold Chain Articles & Analysis
2 news found
Australian biotechnology company, Vaxxas Pty Ltd (Vaxxas), in collaboration with the University of Sydney Institute for Infectious Diseases, Faculty of Medicine and Health, has completed a study assessing the usability and acceptability of its novel High-Density Microarray Patch (HD-MAP) to administer vaccines. The HD-MAP is Vaxxas’ proprietary vaccine patch technology, representing a ...
The global healthcare sector is undergoing significant changes, requiring medical device manufacturing companies to keep up with the fast rate of development. As a pioneering company, B Medical Systems stimulates innovation in the medical device industry with patented solutions. It strives to address unmet needs in the transport, processing and storage of temperature-sensitive materials. Its ...